Literature DB >> 15014591

Treatment of Comorbid Tuberculosis and Depression.

Adam J. Trenton1, Glenn W. Currier.   

Abstract

Tuberculosis (TB) remains a leading infectious cause of mortality worldwide. While the overall prevalence of TB in the United States has declined in the general population, certain groups remain at high risk, including the homeless, those who are HIV seropositive, individuals with a history of alcohol or drug abuse, and immigrants from a country in which TB is endemic. Many recipients of psychiatric services possess 1 or more of these risk factors, and consequently TB may be overrepresented in this population. Conversely, psychiatric illness may develop subsequent to TB infection. Mood disorders seem to be particularly common in TB patients compared with those with other medical diagnoses. It is important that primary care physicians understand the high prevalence of mental illness in TB patients so that proper treatment provisions can be implemented. Likewise, it is important for psychiatrists to understand the clinical manifestations of TB so that when a patient presents with symptoms of TB proper precautions can be taken and appropriate referrals can be made. This article integrates information concerning mental illness in TB patients with diagnostic and treatment guidelines for TB. Brief suggestions are offered for the treatment of TB patients with comorbid mental illness.

Entities:  

Year:  2001        PMID: 15014591      PMCID: PMC181192          DOI: 10.4088/pcc.v03n0610

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  36 in total

1.  Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients.

Authors:  B N van Berckel; R Hijman; J A van der Linden; H G Westenberg; J M van Ree; R S Kahn
Journal:  Biol Psychiatry       Date:  1996-12-15       Impact factor: 13.382

2.  Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A.

Authors:  Z Desta; N V Soukhova; D A Flockhart
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Tuberculosis infection among people with severe mental illness.

Authors:  H L McQuistion; P Colson; R Yankowitz; E Susser
Journal:  Psychiatr Serv       Date:  1997-06       Impact factor: 3.084

4.  Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo.

Authors:  D S Robinson; W Lovenberg; H Keiser; A Sjoerdsma
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

5.  Neurologic and behavioural reactions of tuberculous patients treated with cycloserine.

Authors:  M Pasargiklian; L Biondi
Journal:  Scand J Respir Dis Suppl       Date:  1970

6.  Potential interaction between isoniazid and selective serotonin-reuptake inhibitors.

Authors:  M E Evans; K J Kortas
Journal:  Am J Health Syst Pharm       Date:  1995-10-01       Impact factor: 2.637

Review 7.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

Review 8.  Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.

Authors:  S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1997       Impact factor: 6.447

Review 9.  Monoamine oxidase inhibitors: reversible and irreversible.

Authors:  M V Rudorfer
Journal:  Psychopharmacol Bull       Date:  1992

10.  Isoniazid and antidepressants: is there cause for concern?

Authors:  F K Judd; A M Mijch; A Cockram; T R Norman
Journal:  Int Clin Psychopharmacol       Date:  1994       Impact factor: 1.659

View more
  16 in total

1.  Depression: a silent driver of the global tuberculosis epidemic.

Authors:  Annika Sweetland; Maria Oquendo; Priya Wickramaratne; Myrna Weissman; Milton Wainberg
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

2.  Prevalence of depression in tuberculosis patients in comparison with non-tuberculosis family contacts visiting the DOTS clinic in a Nigerian tertiary care hospital and its correlation with disease pattern.

Authors:  Olusoji Mayow Ige; Victor Olufolahan Lasebikan
Journal:  Ment Health Fam Med       Date:  2011-12

3.  Depression among patients with tuberculosis: determinants, course and impact on pathways to care and treatment outcomes in a primary care setting in southern Ethiopia--a study protocol.

Authors:  Fentie Ambaw; Rosie Mayston; Charlotte Hanlon; Atalay Alem
Journal:  BMJ Open       Date:  2015-07-08       Impact factor: 2.692

Review 4.  New Insights into IDO Biology in Bacterial and Viral Infections.

Authors:  Susanne V Schmidt; Joachim L Schultze
Journal:  Front Immunol       Date:  2014-08-11       Impact factor: 7.561

5.  Psychological Symptoms Before and After a 14-Day Initial Inpatient Treatment in Tuberculosis Patients Compared with Their Primary Caregivers and Healthy Controls.

Authors:  Habib Emami; Taher Modarressi; Kosar Najmi; Golnar Radmand; Fatemeh Monjazebi; Payam Tabarsi; Jörg Richter
Journal:  Tanaffos       Date:  2015

6.  Burden and presentation of depression among newly diagnosed individuals with TB in primary care settings in Ethiopia.

Authors:  Fentie Ambaw; Rosie Mayston; Charlotte Hanlon; Atalay Alem
Journal:  BMC Psychiatry       Date:  2017-02-07       Impact factor: 3.630

7.  Increased Risk of Pulmonary Tuberculosis in Patients with Depression: A Cohort Study in Taiwan.

Authors:  Kao-Chi Cheng; Kuan-Fu Liao; Cheng-Li Lin; Shih-Wei Lai
Journal:  Front Psychiatry       Date:  2017-11-13       Impact factor: 4.157

8.  Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa.

Authors:  Karl Peltzer; Pamela Naidoo; Gladys Matseke; Julia Louw; Gugu McHunu; Bomkazi Tutshana
Journal:  BMC Psychiatry       Date:  2012-07-27       Impact factor: 3.630

9.  Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients.

Authors:  Argiro Pachi; Dionisios Bratis; Georgios Moussas; Athanasios Tselebis
Journal:  Tuberc Res Treat       Date:  2013-04-15

10.  HIV, multidrug-resistant TB and depressive symptoms: when three conditions collide.

Authors:  Mrinalini Das; Petros Isaakidis; Rafael Van den Bergh; Ajay M V Kumar; Sharath Burugina Nagaraja; Asmaa Valikayath; Santosh Jha; Bindoo Jadhav; Joanna Ladomirska
Journal:  Glob Health Action       Date:  2014-09-09       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.